Third, assess product catalog composition
The FDA said these and other companies had made false or misleading claims related to compounded versions of weight loss drugs
Common GLP-1 medications include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), tirzepatide (Mounjaro, Zepbound), and dulaglutide (Trulicity)
Important safety considerations include a boxed warning for medullary thyroid carcinoma risk, monitoring for pancreatitis (severe abdominal pain), gallbladder disease, and potential hypoglycemia when used with insulin or sulfonylureas
Due to the requirement for in-person lab tests, physical exams, and ongoing glucose management, Klinic does not prescribe Ozempic since these steps are necessary for effective diabetes care, which cannot be managed solely through telehealth